Literature DB >> 3768841

Influence of cellular DNA content on survival in differentiated thyroid cancer.

H Joensuu, P Klemi, E Eerola, J Tuominen.   

Abstract

Cellular DNA content was measured using a novel flow cytometric method to analyze paraffin-embedded tissue blocks from 125 patients with differentiated thyroid cancer. DNA aneuploidy was found in 20 (24%) of the 82 papillary, 20 (56%) of the 36 follicular, and in four (57%) of the seven medullary carcinomas. Aneuploidy was found to be more common in the elderly (P less than 0.002), in moderately and poorly differentiated carcinomas (P less than 0.004), and in tumors infiltrating beyond the thyroid capsule (P less than 0.03). Patients with an aneuploid tumor had less favorable cumulative survival (P less than 0.0001) than patients with diploid cancer. However, in papillary and follicular carcinomas, multivariate analysis using stepwise Cox model showed age at diagnosis, follicular type, and tumor invasion beyond the thyroid capsule to be more important independent prognostic factors. Increasing probability of DNA aneuploidy with increasing age explains partially why prognosis of differentiated thyroid carcinoma is poor in older patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768841     DOI: 10.1002/1097-0142(19861201)58:11<2462::aid-cncr2820581119>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

Review 1.  Predictors of thyroid tumor aggressiveness.

Authors:  O H Clark
Journal:  West J Med       Date:  1996-09

2.  Adrenomedullary hyperplasia and phaeochromocytoma. DNA cytophotometric findings in 47 cases.

Authors:  B C Padberg; E Garbe; E Achilles; H Dralle; M Bressel; S Schröder
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 3.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

Review 4.  The study of endocrine tumors by flow and image cytometry.

Authors:  Ingrid Zbieranowski; David Murray
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

5.  Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer.

Authors:  J F Hamming; L J Schelfhout; C J Cornelisse; C J van de Velde; B M Goslings; J Hermans; G J Fleuren
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

6.  Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid.

Authors:  J J Ryan; I D Hay; C S Grant; L M Rainwater; G M Farrow; J R Goellner
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

7.  Adenylate cyclase activity as a predictor of thyroid tumor aggressiveness.

Authors:  A E Siperstein; Q H Zeng; E T Gum; K E Levin; O H Clark
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

8.  Flow cytometric DNA analysis of thyroid carcinoma.

Authors:  A Tsuchiya; K Sekikawa; Y Ando; S Suzuki; I Kimijima; R Abe
Journal:  Jpn J Surg       Date:  1990-09

9.  Descriptive epidemiology of thyroid cancer in the Swiss Canton of Vaud.

Authors:  F Levi; S Franceschi; V C Te; E Negri; C La Vecchia
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

10.  Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors.

Authors:  C S Grant; I D Hay; J J Ryan; E J Bergstralh; L M Rainwater; J R Goellner
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.